SCHEMBL3227093

SCHEMBL3227093

CCCC[Sn](CCCC)(CCCC)c1ccccc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 6/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 2/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TLR8 Q9NR97 5/20 0.34
TDP1 Q9NUW8 2/20 0.32
SKP2 Q13309 1/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PARP1 P09874 1/20 0.30
ADRA2B P18089 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13584337 0.83 TSHR (0.45) CYP1A2CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL1453183 0.78 TSHR (0.36) ALDH1A1TLR8
SCHEMBL3848205 0.76 RECQL (0.36) ALDH1A1
SCHEMBL11202895 0.76 TSHR (0.39) ALDH1A1HSD17B10KDM4EPOLBCYP3A4
SCHEMBL7505763 0.76 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2TLR8TDP1L3MBTL1
SCHEMBL31558464 0.76 SMN1; SMN2 (0.36) ALDH1A1SMN1; SMN2TLR8TDP1L3MBTL1
SCHEMBL1451955 0.73 GABRA1 (0.36) CYP1A2CYP3A4PTGS1
SCHEMBL5952904 0.73 ALDH1A1 (0.36) ALDH1A1TDP1
SCHEMBL1256860 0.73 CA1 (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1CYP3A4
SCHEMBL1453289 0.73 HTR1B (0.40) ALDH1A1KDM4ESMN1; SMN2TDP1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110312007-A1 Detection of Histone Deacetylase Inhibition BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2011-12-22 US disclosed
US-20100062465-A1 Detection of Histone Deacetylase Inhibition BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2010-03-11 US disclosed
WO-2007124435-A2 DETECTION OF HISTONE DEACETYLASE INHIBITION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2007-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312007-A1 Detection of Histone Deacetylase Inhibition HDAC1, HDAC3, HDAC7 CYP1A2 4431/4885CYP2C9 4599/4885CYP2C19 4520/4885
US-20100062465-A1 Detection of Histone Deacetylase Inhibition HDAC1, HDAC3, HDAC11 CYP1A2 4436/4885CYP2C9 4605/4885CYP2C19 4540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.